Location: Home > Pharma China Web Edition
  • search
  • go
  • Industry News
  • 12/27/2025Guangzhou Novaken Pharm Files for HKSE Main Board Listing
  • 12/27/2025Novo Nordisk's Wegovy Approved in China for Cardiovascular Risk Reduct...
  • 12/27/2025Coherent Licenses CBP-1018 to MultiValent Biotherapies in Major Global...
  • 12/23/2025Aurobindo Pharma to Increase Stake in Chinese JV Luoxin Aurovitas
  • 12/23/2025Grand Secures China Rights to World's First Adrenaline Nasal Spray fr...
  • 12/23/2025Ipsen Expands Oncology Pipeline with Global Licensing of Simcere Zaimi...
  • 12/23/2025PepBio Raises Series A Financing to Advance AI-Driven Peptide Drug Pip...
  • 12/22/2025Windward Bio Licenses Long-Acting TSLP/IL-13 Bispecific WIN027 from Qy...
  • 12/22/2025Zelgen Files for Hong Kong IPO, Showcasing Commercial Portfolio and Mu...
  • 12/22/2025AstraZeneca Strengthens KRAS Oncology Strategy with Pan-KRAS Deal from...
  • 12/22/2025Rezubio Raises $20M Series A to Advance Membrane-Anchored Therapeutics...
  • 12/19/2025Insilico Targets US$292 Million in Hong Kong IPO to Advance AI-Driven ...
  • 12/19/2025Fosun Partners with ClavisBio in Global Oncology Collaboration with Op...
  • 12/18/2025Leadingtac Raises Over CNY 200M in Series B to Advance Targeted Prote...
  • 12/18/2025Hansoh Highlights Early Clinical Data for B7-H3 ADC Risvutatug Rezetec...
  • 12/18/2025CSL Elevates China to Core Global Strategic Market
  • 12/18/2025Phil Rivers Raises CNY 100M in Series A1 to Advance Digital Twin–Dr...
  • 12/18/2025Byrtna Secures Angel+ Financing to Advance Circular mRNA In Vivo CAR-T...
  • 12/18/2025Valink and Nona Form Strategic Alliance to Accelerate Novel Biologics...
  • 12/17/2025GE HealthCare Opens New R&D Center in Tianjin
  • 12/17/2025Ocgene Raises $30M Series B to Advance Global Mid-Stage Trials of Opht...
  • 12/17/2025Allin Raises ~$50M in Series A+ to Advance Next-Gen ADC and Multispec...
  • 12/17/2025BMS Expands Antibody Pipeline Thru Global Collaboration With Harbour B...
  • 12/17/2025Hansoh and Glenmark Strike Multi-Regional Licensing Deal for EGFR Inhi...
  • 12/16/2025GeneScience Signs Up to $1.37B Global Licensing Deal for TSHR Antibody...
  • 12/16/2025D3 Bio Raises $108M Series B to Advance Global Phase III Program for ...
  • 12/16/2025Fosun Moves to Acquire Maker of Controversial Alzheimer's Drug
  • 12/16/2025Western Gene Therapy Developers Look to China for Faster, Lower-Cost C...
  • 12/15/2025KYinno Raises ~CNY 250M in Series B to Advance Multispecific Antibod...
  • 12/15/2025Sino Biopharm Wins NMPA Approval for FIC Triple CDK Inhibitor in Breas...
  • Page:2/25 Total number of articles:739: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group